| The immunology of macrophage activation syndrome CB Crayne, S Albeituni, KE Nichols, RQ Cron Frontiers in immunology 10, 433348, 2019 | 618 | 2019 |
| Dectin-1 activation by a natural product β-glucan converts immunosuppressive macrophages into an M1-like phenotype M Liu, F Luo, C Ding, S Albeituni, X Hu, Y Ma, Y Cai, L McNally, ... The Journal of Immunology 195 (10), 5055-5065, 2015 | 157 | 2015 |
| Transcription factor c-Maf is a checkpoint that programs macrophages in lung cancer M Liu, Z Tong, C Ding, F Luo, S Wu, C Wu, S Albeituni, L He, X Hu, D Tieri, ... The Journal of clinical investigation 130 (4), 2081-2096, 2020 | 138 | 2020 |
| Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis S Albeituni, KC Verbist, PE Tedrick, H Tillman, J Picarsic, R Bassett, ... Blood, The Journal of the American Society of Hematology 134 (2), 147-159, 2019 | 134 | 2019 |
| Use of the JAK inhibitor ruxolitinib in the treatment of hemophagocytic lymphohistiocytosis C Keenan, KE Nichols, S Albeituni Frontiers in immunology 12, 614704, 2021 | 103 | 2021 |
| Yeast-derived particulate β-glucan treatment subverts the suppression of myeloid-derived suppressor cells (MDSC) by inducing polymorphonuclear MDSC apoptosis and monocytic MDSC … SH Albeituni, C Ding, M Liu, X Hu, F Luo, G Kloecker, M Bousamra, ... The Journal of Immunology 196 (5), 2167-2180, 2016 | 96 | 2016 |
| Roles of ceramides and other sphingolipids in immune cell function and inflammation S Albeituni, J Stiban The Role of Bioactive Lipids in Cancer, Inflammation and Related Diseases …, 2019 | 94 | 2019 |
| MIF is necessary for late-stage melanoma patient MDSC immune suppression and differentiation K Yaddanapudi, BE Rendon, G Lamont, EJ Kim, N Al Rayyan, J Richie, ... Cancer immunology research 4 (2), 101-112, 2016 | 89 | 2016 |
| Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography SV Hudson, JS Huang, W Yin, S Albeituni, J Rush, A Khanal, J Yan, ... Cancer research 74 (21), 6271-6279, 2014 | 84 | 2014 |
| Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer SH Albeituni, C Ding, J Yan The Cancer Journal 19 (6), 490-501, 2013 | 76 | 2013 |
| JAK/STAT pathway inhibition sensitizes CD8 T cells to dexamethasone-induced apoptosis in hyperinflammation LK Meyer, KC Verbist, S Albeituni, BP Scull, RC Bassett, AN Stroh, ... Blood, The Journal of the American Society of Hematology 136 (6), 657-668, 2020 | 68 | 2020 |
| The effects of β-glucans on dendritic cells and implications for cancer therapy SH Albeituni, J Yan Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2013 | 65 | 2013 |
| Synergistic signaling of TLR and IFNα/β facilitates escape of IL-18 expression from endotoxin tolerance E Verweyen, D Holzinger, T Weinhage, C Hinze, H Wittkowski, P Pickkers, ... American journal of respiratory and critical care medicine 201 (5), 526-539, 2020 | 51 | 2020 |
| Microbiota-dependent signals are required to sustain TLR-mediated immune responses LK Weaver, D Minichino, C Biswas, N Chu, JJ Lee, K Bittinger, S Albeituni, ... JCI insight 4 (1), 2019 | 46 | 2019 |
| Ruxolitinib, a JAK1/2 inhibitor, ameliorates cytokine storm in experimental models of hyperinflammation syndrome E Huarte, MT Peel, K Verbist, BL Fay, R Bassett, S Albeituni, KE Nichols, ... Frontiers in pharmacology 12, 650295, 2021 | 29 | 2021 |
| The immunology of macrophage activation syndrome. Front Immunol. 2019; 10: 119 CB Crayne, S Albeituni, KE Nichols, RQ Cron | 23 | 2019 |
| Actively targeted nanodelivery of echinomycin induces autophagy-mediated death in chemoresistant pancreatic cancer in vivo A Thomas, A Samykutty, JG Gomez-Gutierrez, W Yin, ME Egger, ... Cancers 12 (8), 2279, 2020 | 17 | 2020 |
| The immunology of macrophage activation syndrome. Front Immunol 10: 119 CB Crayne, S Albeituni, KE Nichols, RQ Cron | 17 | 2019 |
| Correction: yeast-derived particulate β-glucan treatment subverts the suppression of myeloid-derived suppressor cells (MDSC) by inducing polymorphonuclear MDSC apoptosis and … SH Albeituni, C Ding, M Liu, X Hu, F Luo, G Kloecker, M Bousamra, ... The Journal of Immunology 196 (9), 3967-3967, 2016 | 5 | 2016 |
| Correction: Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype M Liu, F Luo, C Ding, S Albeituni, X Hu, Y Ma, Y Cai, L McNally, ... The Journal of Immunology 196 (9), 3968-3968, 2016 | 4 | 2016 |
